Current Edition

Upcoming Events

Advertisement

news

Roche revives a closely watched Huntington’s disease drug

Dive Brief: Roche has outlined a new clinical path forward for a closely watched Huntington's disease drug ten months after disappointing Phase 3 study results app...
Continue Reading →
news

Gene therapy developer gets chance at a comeback with Pfizer deal

Voyager's first generation of gene therapies for ALS, Parkinson's and Huntington's disease, all now discontinued, relied on a direct infusion into brain tissue, an in...
Continue Reading →